Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

The Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value of USD 251.06 Million by 2030. In the projection period, the Global Market is forecasted ...

The global Smart Insulin Pens Market is experiencing substantial growth, driven by the increasing prevalence of diabetes, advancements in digital healthcare solutions, and the demand for user-friendly ...

Reusable smart device pens also work alongside a companion app to track dosages and provide much-needed data to help manage diabetes. Smart insulin pens can also: Calculate the needed dose based ...

and smart insulin pen systems. This collaboration is set to connect Abbott's CGM sensor with Medtronic's AID algorithms, ...

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...

Surging Demand for Insulin Dosing Precision: With 35 million insulin-dependent patients worldwide, healthcare systems are prioritizing smart syringes equipped with real-time monitoring. Mobile health ...